StockData
Savara Inc logo

Savara Inc (SVRA) stock

SVRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$4.48+0.02 (+0.34%)

Close on Nov 17, 2026Market cap $920.46MP/E –Yield –

Earnings

Savara's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Savara's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q2 FY2020ended Jun 30, 2020Aug 6, 2020during market hours–––Filing
Q1 FY2020ended Mar 31, 2020May 7, 2020during market hours–––Filing
Q4 FY2019ended Dec 31, 2019Mar 12, 2020during market hours–––Filing
Q3 FY2019ended Sep 30, 2019Nov 7, 2019during market hours–––Filing
Q2 FY2019ended Jun 30, 2019Aug 8, 2019during market hours–––Filing
Q1 FY2019ended Mar 31, 2019May 9, 2019during market hours–––Filing
Q4 FY2018ended Dec 31, 2018Mar 13, 2019during market hours–––Filing
Q3 FY2018ended Sep 30, 2018Nov 7, 2018during market hours–––Filing
Q2 FY2018ended Jun 30, 2018Aug 9, 2018during market hours–––Filing
Q1 FY2018ended Mar 31, 2018May 9, 2018during market hours–––Filing
Q4 FY2017ended Dec 31, 2017Mar 14, 2018during market hours–––Filing
Q3 FY2017ended Sep 30, 2017Nov 8, 2017during market hours–––Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Savara has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Savara puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Savara filed with the SEC as exhibits to Form 8-K or 6-K

See a number that looks wrong?